The Illusion of Consensus

Bret Weinstein joins Rav Arora on The Illusion of Consensus to discuss dating, mating, sex, relationships, marriage, pornography, OnlyFans, dating apps and the collapse of courtship among Gen Z. Weinstein, an evolutionary theorist, author of A Hunter-Gatherer’s Guide to the 21st Century and host of The DarkHorse Podcast, explains modern romance through evolutionary biology, including male mating strategies, monogamy, mate selection and the effects of contraception. The conversation covers Valentine’s Day, sexual signals, promiscuity, long-term commitment, the rise of the “sex recession”, and new concerns around declining dating among young people. Rav and Bret also discuss Joe Rogan, Jordan Peterson, Andrew Tate, Nick Fuentes, The Weeknd, Zayn Malik and Gigi Hadid while examining how pop culture, social media and technology shape relationships today. Subscribe to Rav’s Substack to get podcasts straight to your inbox: https://www.illusionconsensus.com/

Groundbreaking Study Reveals Psilocybin Can CRUSH Smoking Addiction | Dr Matt Johnson Psilocybin Beats Nicotine Patches in BREAKTHROUGH Smoking Trial | Dr Matt Johnson Johns Hopkins Scientist Reveals Psilocybin OUTPERFORMS Patches for Smokers | Dr Matt Johnson Matt Johnson joins Rav Arora on The Illusion of Consensus to discuss his new JAMA Network Open study on psilocybin, nicotine patches, CBT and smoking cessation. A Johns Hopkins psychiatry and behavioural sciences professor, Johnson has been central to modern psychedelic research, including work on psilocybin for addiction, depression and end of life distress. He explains why one psilocybin session paired with CBT showed higher six month smoking abstinence rates than nicotine patch treatment with CBT, and what that could mean for tobacco use disorder. The discussion also covers vaping, nicotine harm reduction, the UK Tobacco and Vapes Bill, addiction treatment, mystical experiences, emotional breakthrough, neuroplasticity, agency and why psychedelics may help people change entrenched behaviour. Rav and his guest examine both the promise and the risks of psychedelic therapy, including bad experiences, vulnerable patients, clinical safeguards and the future of FDA approved addiction treatments. Link to Matt’s Paper: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2846155 Subscribe to Rav’s Substack for exclusive content: https://www.illusionconsensus.com/

Mark Cuban joins Rav Arora on The Illusion of Consensus for a wide-ranging debate on DEI, wokeness, corporate hiring, race-based diversity goals, merit, quotas, and the backlash against progressive workplace policies. The billionaire entrepreneur, Shark Tank investor, Dallas Mavericks minority owner, and Cost Plus Drugs co-founder argues that businesses should cast a wider net for talent while still hiring the most qualified person, as Rav challenges whether corporate diversity pledges after George Floyd and Black Lives Matter became virtue signalling or a form of discrimination. They discuss EEOC data, Starbucks, Nike, JPMorgan, Pfizer, Microsoft, United Airlines, HBCUs, minority representation, universities, DEI departments, activists such as Ibram X. Kendi and Robin DiAngelo, and the Trump administration’s push to dismantle DEI programmes. The conversation also revisits their previous disagreement over Covid mandates, mRNA vaccine side effects, public health ethics, Joe Rogan, pandemic policy, and whether the response to Covid created lasting mistrust in institutions. Cuban and Arora cover how business leaders navigate culture war pressure, shareholder interests, free speech, corporate virtue signalling, political polarisation, independent media, and the future of race, merit, and fairness in American companies. Subscribe to Rav’s Substack for exclusive content: https://www.illusionconsensus.com/ 0:00 - Intro 02:29 — The Clash Begins 04:04 — Mark Cuban Defines DEI His Way 05:52 — “That’s Not What DEI Means!” 08:29 — Are Racial Quotas Real? 12:47 — Corporate Virtue Signalling Exposed 21:13 — Should Race Ever Matter in Hiring? 29:34 — Diversity vs. Meritocracy 48:04 — Do Companies Really Even Follow DEI? 57:42 — Does DEI Actually Work? 01:21:31 — Race-Based Goals vs Pure Merit-Based Hiring 01:36:45 — Final Thoughts and Common Ground 01:38:39 — Arora challenges Cuban on campus censorship 01:41:24 — Cuban on discrimination from both political sides 01:42:59 — Why Cuban required Mavericks staff vaccinations 01:43:57 — Arora disputes community benefit of mandates 01:52:57 — Cuban’s “herd immunity in three months” argument 02:05:02 — FDA internal disagreements over vaccine approval 02:05:31 — White House pressure and military mandates 02:25:00 — Comparing Covid and vaccine-induced myocarditis 02:36:23 — Infection fatality rate and serious adverse events

Kevin Sabet debates Matt Johnson on the Illusion of Consensus podcast with host Rav Arora, covering Trump’s psychedelic executive order, ibogaine, FDA approval, Right to Try, drug scheduling, and the future of psychedelic research. Sabet, a former White House drug policy advisor across the Clinton, Bush, and Obama administrations, argues for caution around psychedelics, marijuana policy, commercial incentives, and overstated medical claims. Johnson, a leading Johns Hopkins psychedelic researcher, responds on psilocybin studies, addiction treatment, depression, safety protocols, REMS, and why accelerated research may still follow the evidence. The discussion also covers Joe Rogan, RFK Jr., Marty Makary, Jay Bhattacharya, ketamine clinics, MDMA, MAPS, cannabis rescheduling, veteran suicide, and the risks of turning experimental drugs into public policy too quickly. Subscribe to Rav’s Substack to get episodes straight to your inbox: https://www.illusionconsensus.com Chapters: 0:00 - Intro 2:05 - Sabet’s Objection to Psychedelics 10:00 - Matt’s Disagreement with Sabet 13:15 - Psychedelic Research Quality 21:10 - Kevin’s Rebuttal 24:00 - Was Joe Rogan Wrong On Ibogaine’s Efficacy 32:50 - Ibogaine Safety Concerns 40:50 - Could The Executive Order Go Too Far 46:10 - Rescheduling and FDA Approval

Dr Matt Johnson joins the Illusion of Consensus podcast with Rav Arora to break down this weekend’s Trump administration’s psychedelic executive order and what it means for FDA approvals, rescheduling, and veteran access to therapies. As a leading Johns Hopkins University psychiatry professor, Dr Matt Johnson shares insights from decades of research into psilocybin, addiction treatment, depression, and end-of-life care. The discussion covers the political shift driven by figures like Donald Trump, Joe Rogan, and Robert F. Kennedy Jr., alongside the growing bipartisan support for psychedelic science. Key topics include breakthrough therapy designations, right-to-try pathways, ibogaine research, and the real-world implications for mental health and veteran suicide prevention. This episode explores how emerging data and policy changes could reshape the future of psychedelic medicine in the United States.Chapters:[0:00] Intro[2:30] Joe Rogan Bashing Nixon[5:20] Rav and Matt’s Proposal[9:40] Calley Means’ Pivotal Role[13:40] Matt Johnson Reacts To The News[18:36] The DEA Bottleneck Problem[23:20] Real Risks of Psychedelics[32:19] Right to Try for Veterans[34:37] Jay Bhattacharya vs Trump[39:40] Jealousy for Rogan[43:51] Do Psychedelics Improve Lives?[49:55] Next Steps for Trump Admin[53:42] End of Psychedelic Prohibition? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.illusionconsensus.com/subscribe